Can the American Thyroid Association Risk of Recurrence Predict Radioiodine Refractory Disease in Differentiated Thyroid Cancer?

Hassan, Aamna; Riaz, Saima; Bashir, Humayun; Nawaz, M Khalid; Hussain, Raza

Hassan, Aamna; Riaz, Saima; Bashir, Humayun; Nawaz, M Khalid; Hussain, Raza.

Afiliação

Hassan A; Department of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
Riaz S; Department of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
Bashir H; Department of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
Nawaz MK; Department of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
Hussain R; Department of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Eur Thyroid J ; 5(4): 261-267, 2016 Dec.

Article em En | MEDLINE | ID: mdl-28101491

Palavras-chave

18F-fludeoxyglucose PET/CT scan; American Thyroid Association risk classification; Differentiated thyroid cancer; Radioiodine refractory disease; TNM in iodine resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Eur Thyroid J Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Paquistão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google